BMY vs FLXS · P/E 17, rev $24.46B vs P/E 15, rev $459.2M
Bristol-Myers Squibb Company (BMY) versus Flexsteel Industries Inc (FLXS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Flexsteel Industries Inc (FLXS) is a furnishings, fixtures & appliances company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FLXS revenue for 2026-06-30 was $459.2M. Net income was $33.1M. Revenue was up 300.6% from 2025-06-30 to 2026-06-30. FLXS currently screens at market cap $199.7M and trailing P/E 14.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FLXS currently screens at market cap $199.7M and trailing P/E 14.7.
Not investment advice. Open the BMY and FLXS stock pages for the full models.
Not investment advice.